DUSA Pharmaceuticals Inc. (DUSA) Q2 2012 Results Earnings Call August 2, 2012 8:30 AM ET Executives Bob Doman – President and CEO Rich Christopher – Vice President, Finance and CFO Analysts Henry Scott – Roth Capital Nick Halen – Sidoti & Company Seamus Fernandez – Leerink Swann Ken Trbovich – C.K. Cooper PresentationOperator
Good day, ladies and gentlemen. And welcome to the DUSA Pharmaceuticals Second Quarter 2012 Corporate Highlights and Financial Results Teleconference. At this time, all participants are in a listen-only mode and later, we will conduct a question-and-answer session, and instructions will be given at that time. (Operator Instructions) As a reminder, this conference is being recorded. I would now like to introduce your host for today’s conference, Bob Doman. Sir, you may begin. Bob Doman Good morning, everyone. Thank you for joining us today for our second quarter 2012 corporate highlights and financial results conference call. After some opening comments I’ll turn the call over to Rich Christopher who will cover our financial results. Please be reminded, while the primary purpose of the call is to review results, be advised that our comments and answers to your questions may contain certain forward-looking statements. The forward-looking statements are subject to a number of risks and uncertainties associated with the company’s business. Additional information which may affect our business prospects is available in the company’s SEC filings. We are pleased to report today that DUSA posted a very positive second quarter of the year. Sales results were strong, gross margin dollars were up significantly and we generated $2.3 million in positive cash flow.